Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 504 | 587 | 506 | 684 | 593 |
| Operating Income | -504 | -587 | -506 | -684 | -593 |
| Interest Expense | 35 | 34 | 27 | 25 | 26 |
| Other Income | 3 | -15 | -213 | 89 | 1 |
| Pre-tax Income | -536 | -635 | -747 | -620 | -619 |
| Net Income Continuous | -536 | -635 | -747 | -620 | -619 |
| Net Income | $-536 | $-635 | $-747 | $-620 | $-619 |
| EPS Basic Total Ops | -1.60 | -2.00 | -2.40 | -1.30 | -2.70 |
| EPS Basic Continuous Ops | -1.58 | -1.99 | -2.42 | -1.37 | -2.65 |
| EPS Diluted Total Ops | -1.60 | -2.00 | -2.40 | -1.30 | -2.70 |
| EPS Diluted Continuous Ops | -1.58 | -1.99 | -2.42 | -1.37 | -2.65 |
| EBITDA(a) | $-504 | $-587 | $-506 | $-684 | $-592 |